Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 10:15AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 26.92B |
| Enterprise Value | 31.67B |
| Trailing P/E | 23.30 |
| Forward P/E | 10.62 |
| PEG Ratio (5 yr expected) | 6.24 |
| Price/Sales (ttm) | 2.79 |
| Price/Book (mrq) | 1.69 |
| Enterprise Value/Revenue | 3.27 |
| Enterprise Value/EBITDA | 14.72 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | -0.06 |
| 52-Week Change 3 | -29.81% |
| S&P500 52-Week Change 3 | 32.30% |
| 52 Week High 3 | 269.43 |
| 52 Week Low 3 | 183.56 |
| 50-Day Moving Average 3 | 201.65 |
| 200-Day Moving Average 3 | 221.18 |
Share Statistics
| Avg Vol (3 month) 3 | 1.05M |
| Avg Vol (10 day) 3 | 1.62M |
| Shares Outstanding 5 | 145.66M |
| Implied Shares Outstanding 6 | 145.66M |
| Float 8 | 145.13M |
| % Held by Insiders 1 | 0.17% |
| % Held by Institutions 1 | 92.66% |
| Shares Short (Sept 13, 2024) 4 | 3.67M |
| Short Ratio (Sept 13, 2024) 4 | 4.8 |
| Short % of Float (Sept 13, 2024) 4 | 2.84% |
| Short % of Shares Outstanding (Sept 13, 2024) 4 | 2.52% |
| Shares Short (prior month Aug 15, 2024) 4 | 2.68M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 3:1 |
| Last Split Date 3 | Jan 18, 2001 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Jun 30, 2024 |
Profitability
| Profit Margin | 11.98% |
| Operating Margin (ttm) | 32.50% |
Management Effectiveness
| Return on Assets (ttm) | 5.19% |
| Return on Equity (ttm) | 7.63% |
Income Statement
| Revenue (ttm) | 9.67B |
| Revenue Per Share (ttm) | 66.66 |
| Quarterly Revenue Growth (yoy) | 0.40% |
| Gross Profit (ttm) | N/A |
| EBITDA | 2.73B |
| Net Income Avi to Common (ttm) | 1.16B |
| Diluted EPS (ttm) | 7.93 |
| Quarterly Earnings Growth (yoy) | -1.40% |
Balance Sheet
| Total Cash (mrq) | 1.91B |
| Total Cash Per Share (mrq) | 13.1 |
| Total Debt (mrq) | 6.66B |
| Total Debt/Equity (mrq) | 41.91% |
| Current Ratio (mrq) | 2.29 |
| Book Value Per Share (mrq) | 109.05 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.78B |
| Levered Free Cash Flow (ttm) | 1.27B |
© 2024 Yahoo. All rights reserved.